SGLT2 inhibitors and kidneys: mechanisms and main effects in diabetes mellitus patients [PDF]
, 2021 Type 2 diabetes mellitus (T2DM) is the cause of the development of diabetic nephropathy — a complication that determines the high degree of disability and mortality of such patients. Until recently, approaches to normalizing glucose levels did not have a
Sergey B. Shustov +3 more
core +1 more source
Перспективы применения хондроитина сульфата и глюкозамина сульфата при остеоартрите в сочетании с патологией почек и мочевыделительной системы [PDF]
, 2020 Introduction. Chondroitin sulfate (CS) and glucosamine sulfate (GS), widely used as chondroprotectors, can maintain the normal functioning of the urinary system but their effect has not been analyzed systematically.Aim: to perform a systematic analysis ...
A. Lila М. +7 more
core +2 more sources
Канальцевый транспорт в почках больных эссенциальной гипертензией в сочетании с сахарным диабетом ІІ типа [PDF]
, 2018 Изучены сегментарная канальцевая реабсорбция натрия и натриуретическая и водовыделительная функция почек у 32 больных эссенциальной гипертензией в сочетании с сахарным диабетом II типа (основная группа), у 30 больных эссенциальной гипертензией и 30 ...
Коломиец, В. В. +1 more
core +2 more sources
ПАТОФІЗІОЛОГІЯ ПРОТЕЇНУРІЇ У ДИНАМІЦІ РОЗВИТКУ АЛОКСАНІНДУКОВАНОГО ЕКСПЕРИМЕНТАЛЬНОГО ЦУКРОВОГО ДІАБЕТУ [PDF]
, 2021 Summary. Diabetic kidney disease (DKD) is a clinical diagnosis that has historically been based on the detection of proteinuria in a patient with diabetes mellitus, and until recently, proteinuria was thought to reflect the extent of glomerular disease ...
Olenovych, О. А.
core +2 more sources
Effect of SGLT2 inhibitors on the course of chronic heart failure in patients with type 2 diabetes mellitus [PDF]
, 2022 Diabetes mellitus (DM) is a group of metabolic diseases characterized by chronic hyperglycemia, which is the result of impaired insulin secretion, insulin action, or both.
A. N. Payudis +6 more
core +3 more sources
Gliclazide MR in the structure of antihyperglycemic therapy according to the data of Moscow region diabetes register [PDF]
, 2022 Background: Sulfonylureas (SU) are often used for second and third line type 2 diabetes mellitus (T2DM) therapy. Currently, there are no unified recommendations governing the choice of drugs for the second line therapy.
A. V. Dreval +3 more
core +1 more source
Kidney pathology and nephroprotection among patients with COVID-19 [PDF]
, 2021 А number of medical articles, documents and described clinical cases were studied to analyze the dependence of kidney function on COVID-19 disease. A number of conclusions were drawn about the significance of kidney involvement in the clinical picture of
Tsorieva, A. A. +3 more
core
Эффекты блокаторов рецепторов к ангиотензину II у пациентов со стабильной ишемической болезнью сердца [PDF]
, 2022 Highlights. The review synthesizes the results of clinical studies on the use of sartans. This topic is highly relevant due to the antihypertensive, metabolic and organ-protective effect of sartans, which can positively affect the course of coronary ...
A. M. Kochergina +3 more
core +2 more sources
Механизмы нефропротекторных свойств статинов при гентамициновой острой почечной недостаточности [PDF]
, 2016 ПОЧЕЧНАЯ НЕДОСТАТОЧНОСТЬ ОСТРАЯСТАТИНЫАТОРВАСТАТИНЛОВАСТАТИНСИМВАСТАТИННЕФРОПРОТЕКЦИЯЭКСПЕРИМЕНТЫ НА ...
Заморский, И. И. +3 more
core +1 more source
Standards of specialized diabetes care. Edited by Dedov I.I., Shestakova M.V., Mayorov A.Yu. 10th edition [PDF]
, 2022 Dear Colleagues!We are glad to present the 10th Edition (revised) of the Standards of Specialized Diabetes Care. These evidence-based guidelines were designed to standardize and facilitate diabetes care in all regions of the Russian Federation.The ...
Alexander Yu. Mayorov +35 more
core +1 more source